Online citations, reference lists, and bibliographies.
← Back to Search

Cyclosporin A For Psoriasis.

W. Müller, B. Herrmann
Published 1979 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references



This paper is referenced by
Immunhistochemische Analyse der Expression von humanem Beta-Defensin-2 und des inflammatorischen Infiltrates in entzündlichen Dermatosen zur Abgrenzung gegenüber der Psoriasis vulgaris
Thorsten Renken (2015)
PSORIASIS: CURRENT THERAPEUTICAL STRATEGIES
C. Geilen (2008)
10.1016/j.jaad.2009.05.017
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference.
D. Rosmarin (2010)
10.1016/0190-9622(90)70350-Q
Systemic and local administration of cyclosporine in the treatment of psoriasis.
C. E. Griffiths (1990)
10.2336/NISHINIHONHIFU.52.1046
Chronic administration of cyclosporin for psoriasis.
H. Takematsu (1990)
10.1016/0140-6736(92)91757-Y
Inhibition of contact allergy reactions by topical FK506
AnttiI. Lauerma (1992)
10.1172/JCI5857
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris.
J. R. Abrams (1999)
10.1016/J.CLINDERMATOL.2007.08.012
Immunopathogenesis and role of T cells in psoriasis.
K. Ghoreschi (2007)
10.1016/j.vascn.2019.106657
Murine models of psoriasis and its applications in drug development.
T. Luo (2019)
10.1016/S0041-1345(98)02075-2
The contribution of cyclosporine A to the understanding and treatment of autoimmune diseases.
J. F. Bach (1999)
10.1007/978-3-642-57191-6_53
Rolle des Integrins αE(CD103)β7 auf epidermotropen T-Lymphozyten in psoriatischen Läsionen und in einem T-Zell-vermittelten murinen Psoriasis-Modell
M. Schön (2000)
Cyclosporine in childhood psoriasis.
E. Mahé (2001)
10.1016/j.jaad.2009.03.027
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents.
A. Menter (2009)
Post Marketing Surveillance Study to Assess Safety and Efficacy of Cyclosporine Micro-Emulsion (Neoral ® ) Treatment in Psoriasis Patients
Ümmühan Kiremitçi (2011)
10.1007/978-3-642-57539-6_18
Psoriasis vulgaris: Vom Aussatz zur Autoimmunerkrankung
J. Prinz (2002)
10.1016/S0140-6736(84)91194-2
CYCLOSPORIN FOR PSORIASIS
J. Harper (1984)
10.1016/0190-9622(92)70228-8
Cyclosporine therapy for psoriasis: a cell cycle-derived dosing schedule.
M. Goodman (1992)
10.1016/0190-9622(92)70065-N
Morphologic renal changes during cyclosporine treatment of psoriasis. Studies on pretreatment and posttreatment kidney biopsy specimens.
H. Zachariae (1992)
10.20344/AMP.4061
[Psoriasis and cardiovascular disease].
T. Torres (2013)
10.1111/j.1365-2133.1996.tb00708.x
Increased bioavailability and improved efficacy, in severe psoriasis, of a new microemulsion formulation of cyclosporin *
W. Gulliver (1996)
10.1111/j.1440-0960.1997.tb01697.x
Generalized pustular psoriasis responsive to PUVA and oral cyclosporin therapy
M. J. Hunt (1997)
10.3109/09546639309080549
Cyclosporin in the treatment of psoriasis
J. I. Youn (1993)
10.2336/NISHINIHONHIFU.53.1242
Intractable arthropathic psoriasis for which cyclosporin A was effective.
Hidetsugu Torii (1991)
10.2336/NISHINIHONHIFU.57.1234
Treatment evaluation of cyclosporin according to type of patients with psoriasis.
Ken'ichi Shibue (1995)
10.6003/JTAD.1483R1
Lepra vulgaris. History of Psoriasis
G. Burg (2014)
10.1016/S0140-6736(89)92941-3
USE OF CYCLOSPORIN IN PSORIASIS
J. Bos (1989)
10.1007/978-3-642-39546-8_37
Systemic Treatment of Hand Eczema: Cyclosporine
Cooper C. Wriston (2014)
10.1007/s00109-003-0460-9
A molecule solves psoriasis? Systemic therapies for psoriasis inducing interleukin 4 and Th2 responses
K. Ghoreschi (2003)
10.1016/S0733-8635(03)00124-4
From laboratory to clinic: rationale for biologic therapy.
S. Mehlis (2004)
10.1016/S0190-9622(88)70040-7
Improvement of psoriasis vulgaris after intralesional injections of 15-hydroxyeicosatetraenoic acid (15-HETE).
K. Fogh (1988)
10.1111/j.1365-2133.1988.tb01768.x
The pathomechanisms of psoriasis; the skin immune system and cyclosporin
J. Bos (1988)
10.1016/0022-202X(89)90195-4
Cyclosporin A inhibits directly in vivo keratinocyte proliferation of living human skin.
A. Urabe (1989)
See more
Semantic Scholar Logo Some data provided by SemanticScholar